NDC 68001-313 – Azacitidine

Azacitidine 100 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous

Human Prescription Drug 1 recall

Product NDC68001-313

Product details

Brand name
Azacitidine
Generic name
Azacitidine
Labeler
BluePoint Laboratories
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous, Subcutaneous
Marketing category
NDA · NDA208216
Marketed since
July 1, 2017
Marketing end
December 31, 2026
Pharmacologic class
Nucleoside Metabolic Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Azacitidine →

Package NDC codes (1)

Package NDCDescriptionSince
68001-313-561 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68001-313-56)Jul 1, 2017

Recalls mentioning this NDC

Other Azacitidine products